Synthesis and in vitro evaluation of sugar-modified carboranyluridines

Bioorganic and Medicinal Chemistry Letters

Volumn 6, Issue 15, 1996, Pages 1855-1858

  Imamura, Ken ichiro ^a   Yamamoto, Yoshinori ^a  

^a TOHOKU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

5 CARBORANYLURIDINE; UNCLASSIFIED DRUG; URIDINE DERIVATIVE;

ARTICLE; CELL LINE; CONTROLLED STUDY; CYTOTOXICITY; DRUG SYNTHESIS; DRUG UPTAKE; FIBROBLAST; HUMAN; HUMAN CELL; TUMOR CELL;

EID: 0030572501     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0960-894X(96)00330-7     Document Type: Article

References (17)

1. (1) Barth, R. F.; Soloway, A. H.; Fairchild, R. G. Cancer Res. 1990, 50, 1061-1071.
2. (2) (a) Kobayashi, T.; Kanda, K. Radiat. Res. 1982, 91, 77-94.
3. (b) Gabel, D.; Foster, S.; Fairchild, R. G. Radiat. Res. 1987, 111, 14-25.
4. (3) Yamamoto, Y.; Seko, T.; Nakamura, H.; Nemoto, H.; Hojo, H.; Mukai, N.; Hashimoto, Y. J. Chem. Soc., Chem. Commun. 1992, 157-158. 5-Dihydroxy-boryl-2′-deoxyuridine was synthesized by Schinazi group in 1985, although it did not contain carborane moiety ; Schinazi, R. F.; Prusoff, W. H. J. Org. Chem. 1985, 50, 841-847.
5. (3) Yamamoto, Y.; Seko, T.; Nakamura, H.; Nemoto, H.; Hojo, H.; Mukai, N.; Hashimoto, Y. J. Chem. Soc., Chem. Commun. 1992, 157-158. 5-Dihydroxy-boryl-2′-deoxyuridine was synthesized by Schinazi group in 1985, although it did not contain carborane moiety ; Schinazi, R. F.; Prusoff, W. H. J. Org. Chem. 1985, 50, 841-847.
6. (4) Takagaki, M. "Proceedings of Workshop on BNCT at Res. Reac. Inst., Kyoto Univ" KURRI-TR-365, 1992, 2-4.
7. (5) (a) Norbeck, D. W.; Spanton, S.; Broder, S.; Mitsuya, H. Tetrahedron Lett. 1989, 30, 6263-6266.
8. (b) Doong, S.-L.; Tsai, C.-H.; Schinazi, R. F.; Liotta, D. C.; Cheng, Y.-C. Proc. Natl. Acad. Sci. U.S.A. 1991, 88, 8495-8499.
9. (6) Robins, M. J.; Barr, P. J. Tetrahedron Lett. 1981, 22, 421-424.
10. (7) Satsumabayashi, S.; Irioka, S.; Kudo, H. Bull. Chem. Soc. Jpn. 1972, 45, 913-915.
11. (8) Choi, W.-B.; Wilson, L. J.; Yeola, S.; Liotta, D. C.; Schinazi, R. F. J. Am. Chem. Soc. 1991, 113, 9377-9379.
12. (9) Taniguchi, M.; Koga, K.; Yamada, S. Tetrahedron 1974, 30, 3547-3552.
13. (10) Kawakami, H.; Ebata, T.; Koseki, K.; Matsumoto, K.; Matsushita, H.; Naoi, Y.; Itoh, K. Heterocycles 1991, 32, 2451-2470.
14. (11) Wilson, L. J.; Liotta, D. Tetrahedron Lett. 1990, 31, 1815-1818.
15. (12) Another synthesis and biological evaluation of 5: Schinazi, R. F.; Goudgaon, N.; Soria, J.; Liotta, D. C. In Advanced in Neutron Capture Therapy; Soloway, A. H. et. al., Eds.; Plenum Press: New York, 1993; PP285-288.
16. (13) Nemoto, H.; Cai, J.-P.; Asao, N.; Iwamoto, S.; Yamamoto, Y. J. Med. Chem. 1995, 38, 1673-1678.
17. (14) Biological data of CU (1) were cited from H. Nakamura's master thesis (Tohoku University, 1992).